Menu
GeneBe

13-24223120-A-T

Variant summary

Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2

The NM_001166271.3(SPATA13):​c.191A>T​(p.Glu64Val) variant causes a missense change. The variant allele was found at a frequency of 0.0000767 in 1,551,602 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 11/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.00047 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000034 ( 0 hom. )

Consequence

SPATA13
NM_001166271.3 missense

Scores

4
8

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 4.10
Variant links:
Genes affected
SPATA13 (HGNC:23222): (spermatogenesis associated 13) Enables guanyl-nucleotide exchange factor activity and identical protein binding activity. Involved in cell migration; plasma membrane bounded cell projection assembly; and regulation of cell migration. Located in several cellular components, including filopodium; lamellipodium; and ruffle membrane. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -8 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.038067073).
BS2
High AC in GnomAd4 at 72 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
SPATA13NM_001166271.3 linkuse as main transcriptc.191A>T p.Glu64Val missense_variant 2/13 ENST00000382108.8
SPATA13NM_001286792.2 linkuse as main transcriptc.377A>T p.Glu126Val missense_variant 4/15
SPATA13NM_153023.4 linkuse as main transcriptc.-222-26357A>T intron_variant

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
SPATA13ENST00000382108.8 linkuse as main transcriptc.191A>T p.Glu64Val missense_variant 2/135 NM_001166271.3 Q96N96-6
SPATA13ENST00000424834.6 linkuse as main transcriptc.191A>T p.Glu64Val missense_variant 4/151 Q96N96-6
SPATA13ENST00000382095.8 linkuse as main transcriptc.-222-26357A>T intron_variant 2 Q96N96-1
SPATA13ENST00000466831.2 linkuse as main transcriptn.513A>T non_coding_transcript_exon_variant 2/22

Frequencies

GnomAD3 genomes
AF:
0.000473
AC:
72
AN:
152218
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00157
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000327
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.000958
GnomAD3 exomes
AF:
0.0000448
AC:
7
AN:
156268
Hom.:
0
AF XY:
0.0000362
AC XY:
3
AN XY:
82848
show subpopulations
Gnomad AFR exome
AF:
0.000631
Gnomad AMR exome
AF:
0.0000405
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.0000439
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000336
AC:
47
AN:
1399384
Hom.:
0
Cov.:
29
AF XY:
0.0000348
AC XY:
24
AN XY:
690200
show subpopulations
Gnomad4 AFR exome
AF:
0.00101
Gnomad4 AMR exome
AF:
0.000112
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.0000126
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00
Gnomad4 OTH exome
AF:
0.000172
GnomAD4 genome
AF:
0.000473
AC:
72
AN:
152218
Hom.:
0
Cov.:
33
AF XY:
0.000484
AC XY:
36
AN XY:
74370
show subpopulations
Gnomad4 AFR
AF:
0.00157
Gnomad4 AMR
AF:
0.000327
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.00
Gnomad4 OTH
AF:
0.000958
Alfa
AF:
0.0000900
Hom.:
0
Bravo
AF:
0.000442
ExAC
AF:
0.000118
AC:
3

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsOct 26, 2021The c.191A>T (p.E64V) alteration is located in exon 2 (coding exon 1) of the SPATA13 gene. This alteration results from a A to T substitution at nucleotide position 191, causing the glutamic acid (E) at amino acid position 64 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Benign
-0.35
T
BayesDel_noAF
Benign
-0.29
CADD
Benign
20
DANN
Uncertain
0.98
Eigen
Benign
-0.26
Eigen_PC
Benign
-0.34
FATHMM_MKL
Uncertain
0.93
D
M_CAP
Uncertain
0.29
D
MetaRNN
Benign
0.038
T;T
MetaSVM
Benign
-0.61
T
MutationTaster
Benign
1.0
N;N
PrimateAI
Benign
0.43
T
Sift4G
Uncertain
0.041
D;D
Vest4
0.25
MVP
0.63
MPC
0.91
ClinPred
0.52
D
GERP RS
1.4
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
2.0
gMVP
0.53

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs369038043; hg19: chr13-24797258; API